FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan
      Dashboard

      Novo Signs $1.3 Billion Nanexa Deal for Long-Acting Drugs

      Novo Nordisk A/S signed a deal worth as much as €1.165 billion ($1.3 billion) with Sweden’s Nanexa AB, betting on a technology that could mean patients need only one obesity shot every few months.

      Source: Bloomberg
      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud